Shs · CUSIP 74346M505 · who reports it, how much, and how much it matters to them
8 of the 720 hedge fund managers we track reported shares of ProMIS Neurosciences Inc. (Nasdaq: PMN) on Form 13F for 30 June 2026. Between them they reported USD 30m. The largest position belongs to Deep Track Capital, at USD 11m. The manager with the most riding on it is Ally Bridge Group (Ny), where it is 7.2% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Deep Track Capital1 fund on PPLI.com | USD 11m | 0.2% |
| 2 | Ally Bridge Group (Ny)3 funds on PPLI.com | USD 8.2m | 7.2% |
| 3 | Sphera Funds Management1 fund on PPLI.com | USD 4.3m | 0.6% |
| 4 | Adage Capital Management1 fund on PPLI.com | USD 2.2m | 0.0% |
| 5 | 683 Capital Management2 funds on PPLI.com | USD 1.3m | 0.1% |
| 6 | Great Point Partners2 funds on PPLI.com | USD 1.1m | 0.2% |
| 7 | Boothbay Fund Management2 funds on PPLI.com | USD 817,000 | 0.0% |
| 8 | Millennium Management6 funds on PPLI.com | USD 738,000 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Ally Bridge Group (Ny) | USD 8.2m | 7.2% |
| 2 | Sphera Funds Management | USD 4.3m | 0.6% |
| 3 | Great Point Partners | USD 1.1m | 0.2% |
| 4 | Deep Track Capital | USD 11m | 0.2% |
| 5 | 683 Capital Management | USD 1.3m | 0.1% |
| 6 | Boothbay Fund Management | USD 817,000 | 0.0% |
| 7 | Adage Capital Management | USD 2.2m | 0.0% |
| 8 | Millennium Management | USD 738,000 | 0.0% |
ProMIS Neurosciences Inc. trades under the symbol PMN on the Nasdaq. Its CUSIP, the code used on Form 13F, is 74346M505.
8 of the 720 hedge fund managers PPLI.com tracks reported ProMIS Neurosciences Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Deep Track Capital (USD 11m), Ally Bridge Group (Ny) (USD 8.2m), Sphera Funds Management (USD 4.3m), Adage Capital Management (USD 2.2m) and 683 Capital Management (USD 1.3m).
8 managers in our coverage reported it, and between them they run 18 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Ally Bridge Group (Ny), where the position was 7.2% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with ProMIS Neurosciences Inc. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.